ripekg:evaluation/RIPEA2D3EB3B0F74C441B |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
prov:startedAtTime |
2026-03-02T15:49:14.437664Z |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA2D3EB3B0F74C441B |
ripekg:publication-details/RIPEA2D3EB3B0F74C441BEffects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
ripekg:registry-evidence/RIPEA2D3EB3B0F74C441B |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
ripekg:retraction-notice/8929Patients with polymorphic light eruption have decreased serum levels of 25-hydroxyvitamin-D3 that increase upon 311 nm UVB photohardening |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |
ripekg:study-design-evidence/RIPEA2D3EB3B0F74C441B |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA2D3EB3B0F74C441B |